News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CMC Biopharmaceuticals A/S And Resistentia AB Announce A Development And Manufacturing Agreement


10/19/2005 5:09:18 PM

CMC Biopharmaceuticals A/S (CMC), a Copenhagen-based contract manufacturing organization, and Resistentia Pharmaceuticals AB, a drug development company based in Uppsala, Sweden today announced that they have entered into a development and manufacturing agreement for the cGMP production of a fusion protein. The product which is an immunotherapeutic reagent used for the treatment of IgE-mediated allergies will be manufactured at CMC’s facility in Copenhagen.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES